Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

Bibliographic Details
Main Authors: Becker, Jürgen C., Andersen, Mads H., Hofmeister-Müller, Valeska, Wobser, Marion, Frey, Lidia, Sandig, Christiane, Walter, Steffen, Singh-Jasuja, Harpreet, Kämpgen, Eckhart, Opitz, Andreas, Zapatka, Marc, Bröcker, Eva-B., thor Straten, Per, Schrama, David, Ugurel, Selma
Format: Online
Language:English
Published: Springer-Verlag 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493663/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493663/

Similar Items